Biologics: a new option in treatment of chronic rhinosinusitis with nasal polyps.
10.3760/cma.j.cn115330-20210509-00260
- Author:
Cheng Shuo WANG
1
;
Luo ZHANG
2
Author Information
1. Beijing Key Laboratory of Nasal Diseases, Beijing Institute of Otolaryngology, Beijing 100005, China.
2. Department of Otolaryngology Head and Neck Surgery, Beijing TongRen Hospital, Capital Medical University, CAMS Innovation Fund for Medical Sciences, Beijing 1000730, China Department of Allergy, Beijing TongRen Hospital, Capital Medical University, Beijing 100730, China.
- Publication Type:Journal Article
- MeSH:
Biological Products;
Chronic Disease;
Humans;
Nasal Polyps/drug therapy*;
Rhinitis/drug therapy*;
Sinusitis/drug therapy*
- From:
Chinese Journal of Otorhinolaryngology Head and Neck Surgery
2021;56(10):1023-1027
- CountryChina
- Language:Chinese
